XML 346 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue $ 2,090 $ 9,979 $ 8,341
Grant revenue 13,528 7,409 3,427
Total revenue 15,618 17,388 11,768
General and administrative expenses (60,991) (57,199) (49,440)
Research and development expenses (152,433) (110,471) (81,859)
Total operating expense (213,425) (167,671) (131,299)
Other income/(expense):      
Gain on deconsolidation of subsidiary 27,251 0 0
Gain/(loss) on investment held at fair value (32,060) 179,316 232,674
Realized loss on sale of investments (29,303) (20,925) (54,976)
Other income/(expense) 8,131 1,592 1,035
Other income/(expense) (25,981) 159,983 178,732
Net finance income/(costs) 138,924 5,050 (6,115)
Share of net loss of associates accounted for using the equity method (27,749) (73,703) (34,117)
Gain on dilution of ownership interest in associate 28,220 0 0
Impairment of investment in associate 8,390 0 0
Income/(loss) before taxes (92,783) (58,953) 18,969
Finance income/(costs) – IFRS 9 fair value accounting 137,063 9,606 (4,351)
Share-based payment expense (14,699) (13,950) (10,718)
Depreciation of tangible assets (5,800) (4,300) (3,900)
Depreciation (3,047) (2,938) (2,700)
Taxation 55,719 (3,756) (14,401)
Income/(Loss) for the year (37,065) (62,709) 4,568
Other comprehensive income/(loss) (379) 0 469
Total comprehensive income/(loss) for the year (37,444) (62,709) 5,037
Total comprehensive income/(loss) attributable to:      
Owners of the Company (50,733) (60,558) 6,454
Non-controlling interests 13,290 (2,151) (1,417)
Consolidated Statements of Financial Position      
Total assets 702,647 946,006  
Total liabilities 155,057 361,859  
Liabilities, intercompany eliminations between parent company and reportable segments 255,500 233,300  
Internal      
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue 0 8,129 5,297
Grant revenue 2,826 1,253 1,563
Total revenue 2,826 9,382 6,860
General and administrative expenses (8,301) (8,673) (3,482)
Research and development expenses (116,054) (65,444) (45,346)
Total operating expense (124,355) (74,118) (48,828)
Other income/(expense):      
Gain on deconsolidation of subsidiary 0    
Gain/(loss) on investment held at fair value 0 0 0
Realized loss on sale of investments 0 0 0
Gain/(loss) on disposal of assets     (15)
Other income/(expense) (204) 0 0
Other income/(expense) (204) (1) (15)
Net finance income/(costs) 615 (16) 19
Share of net loss of associates accounted for using the equity method 0 0 0
Gain on dilution of ownership interest in associate 0    
Impairment of investment in associate 0    
Income/(loss) before taxes (121,118) (64,753) (41,964)
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets (114,255) (60,368) (38,349)
Finance income/(costs) – IFRS 9 fair value accounting 0 0 0
Share-based payment expense (5,136) (3,066) (2,762)
Depreciation of tangible assets (1,727) (1,319) (854)
Depreciation 0 0 0
Amortization of intangible assets 0 0 0
Taxation 0 0 0
Income/(Loss) for the year (121,118) (64,753) (41,964)
Other comprehensive income/(loss) 0 0 0
Total comprehensive income/(loss) for the year (121,118) (64,753) (41,964)
Total comprehensive income/(loss) attributable to:      
Owners of the Company (121,118) (64,657) (41,773)
Non-controlling interests 0 (96) (191)
Consolidated Statements of Financial Position      
Total assets 51,599 125,726  
Total liabilities 271,186 228,789  
Net assets/(liabilities) (219,587) (103,063)  
Controlled founded entities      
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue 1,500 1,500 896
Grant revenue 10,702 6,156 1,864
Total revenue 12,202 7,656 2,760
General and administrative expenses (16,462) (17,504) (10,752)
Research and development expenses (34,668) (40,667) (33,152)
Total operating expense (51,130) (58,171) (43,904)
Other income/(expense):      
Gain on deconsolidation of subsidiary 0    
Gain/(loss) on investment held at fair value 0 0 0
Realized loss on sale of investments 0 0 0
Gain/(loss) on disposal of assets     (15)
Other income/(expense) (3) 70 100
Other income/(expense) (3) 70 85
Net finance income/(costs) 138,006 7,528 (4,352)
Share of net loss of associates accounted for using the equity method 0 0 0
Gain on dilution of ownership interest in associate 0    
Impairment of investment in associate 0    
Income/(loss) before taxes 99,075 (42,917) (45,410)
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets (32,468) (44,335) (36,736)
Finance income/(costs) – IFRS 9 fair value accounting 140,056 10,322 (3,492)
Share-based payment expense (4,703) (6,224) (2,469)
Depreciation of tangible assets (2,526) (1,506) (1,528)
Depreciation (1,283) (1,174) (1,186)
Amortization of intangible assets 0 0 0
Taxation 0 0 (1)
Income/(Loss) for the year 99,075 (42,917) (45,411)
Other comprehensive income/(loss) 0 0 0
Total comprehensive income/(loss) for the year 99,075 (42,917) (45,411)
Total comprehensive income/(loss) attributable to:      
Owners of the Company 85,471 (41,283) (44,506)
Non-controlling interests 13,604 (1,634) (905)
Consolidated Statements of Financial Position      
Total assets 35,341 64,508  
Total liabilities 76,635 209,212  
Net assets/(liabilities) (41,294) (144,704)  
Non-controlled founded entities      
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue 81 115 93
Grant revenue 0 0 0
Total revenue 81 115 93
General and administrative expenses (1,296) (3,225) (2,939)
Research and development expenses (826) (3,116) (3,128)
Total operating expense (2,122) (6,341) (6,067)
Other income/(expense):      
Gain on deconsolidation of subsidiary 0    
Gain/(loss) on investment held at fair value 0 0 0
Realized loss on sale of investments 0 0 0
Gain/(loss) on disposal of assets     0
Other income/(expense) 0 0 0
Other income/(expense) 0 0 0
Net finance income/(costs) (3,045) (784) (852)
Share of net loss of associates accounted for using the equity method 0 0 0
Gain on dilution of ownership interest in associate 0    
Impairment of investment in associate 0    
Income/(loss) before taxes (5,085) (7,010) (6,826)
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets (2,079) (6,248) (5,866)
Finance income/(costs) – IFRS 9 fair value accounting (2,993) (716) (859)
Share-based payment expense (8) (32) (83)
Depreciation of tangible assets (4) (12) (17)
Depreciation 0 0 0
Amortization of intangible assets (1) (2) (1)
Taxation 0 0 0
Income/(Loss) for the year (5,085) (7,010) (6,826)
Other comprehensive income/(loss) 0 0 0
Total comprehensive income/(loss) for the year (5,085) (7,010) (6,826)
Total comprehensive income/(loss) attributable to:      
Owners of the Company (4,755) (6,574) (6,519)
Non-controlling interests (330) (436) (306)
Consolidated Statements of Financial Position      
Total assets 0 1,765  
Total liabilities 0 19,645  
Net assets/(liabilities) 0 (17,880)  
Parent company and other      
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue 509 235 2,054
Grant revenue 0 0 0
Total revenue 509 235 2,054
General and administrative expenses (34,933) (27,797) (32,267)
Research and development expenses (885) (1,244) (234)
Total operating expense (35,817) (29,041) (32,500)
Other income/(expense):      
Gain on deconsolidation of subsidiary 27,251    
Gain/(loss) on investment held at fair value (32,060) 179,316 232,674
Realized loss on sale of investments (29,303) (20,925) (54,976)
Gain/(loss) on disposal of assets     0
Other income/(expense) 8,338 1,523 965
Other income/(expense) (25,775) 159,914 178,662
Net finance income/(costs) 3,348 (1,679) (930)
Share of net loss of associates accounted for using the equity method (27,749) (73,703) (34,117)
Gain on dilution of ownership interest in associate 28,220    
Impairment of investment in associate 8,390    
Income/(loss) before taxes (65,655) 55,727 113,170
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets (57,452) 63,628 121,644
Finance income/(costs) – IFRS 9 fair value accounting 0 0 0
Share-based payment expense (4,852) (4,628) (5,405)
Depreciation of tangible assets (1,588) (1,510) (1,547)
Depreciation (1,764) (1,764) (1,523)
Amortization of intangible assets 0 0 0
Taxation 55,719 (3,756) (14,400)
Income/(Loss) for the year (9,936) 51,971 98,769
Other comprehensive income/(loss) (379) 0 469
Total comprehensive income/(loss) for the year (10,316) 51,971 99,238
Total comprehensive income/(loss) attributable to:      
Owners of the Company (10,331) 51,956 99,253
Non-controlling interests 15 15 (15)
Consolidated Statements of Financial Position      
Total assets 615,707 754,007  
Total liabilities (192,763) (95,787)  
Net assets/(liabilities) 808,470 849,794  
Operating segments      
Consolidated Statements of Comprehensive Income/(Loss)      
Contract revenue 2,090 9,979 8,341
Grant revenue 13,528 7,409 3,427
Total revenue 15,618 17,388 11,768
General and administrative expenses (60,991) (57,199) (49,440)
Research and development expenses (152,433) (110,471) (81,859)
Total operating expense (213,425) (167,671) (131,299)
Other income/(expense):      
Gain on deconsolidation of subsidiary 27,251    
Gain/(loss) on investment held at fair value (32,060) 179,316 232,674
Realized loss on sale of investments (29,303) (20,925) (54,976)
Gain/(loss) on disposal of assets     (30)
Other income/(expense) 8,131 1,593 1,065
Other income/(expense) (25,981) 159,983 178,732
Net finance income/(costs) 138,924 5,050 (6,115)
Share of net loss of associates accounted for using the equity method (27,749) (73,703) (34,117)
Gain on dilution of ownership interest in associate 28,220    
Impairment of investment in associate 8,390    
Income/(loss) before taxes (92,783) (58,953) 18,969
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets (206,254) (47,323) 40,694
Finance income/(costs) – IFRS 9 fair value accounting 137,063 9,606 (4,351)
Share-based payment expense (14,699) (13,950) (10,718)
Depreciation of tangible assets (5,845) (4,347) (3,945)
Depreciation (3,047) (2,938) (2,709)
Amortization of intangible assets (1) (2) (1)
Taxation 55,719 (3,756) (14,401)
Income/(Loss) for the year (37,065) (62,709) 4,568
Other comprehensive income/(loss) (379) 0 469
Total comprehensive income/(loss) for the year (37,444) (62,709) 5,037
Total comprehensive income/(loss) attributable to:      
Owners of the Company (50,733) (60,558) 6,454
Non-controlling interests 13,290 (2,151) $ (1,417)
Consolidated Statements of Financial Position      
Total assets 702,647 946,006  
Total liabilities 155,057 361,859  
Net assets/(liabilities) $ 547,589 $ 584,147